JP2003522795A5 - - Google Patents

Download PDF

Info

Publication number
JP2003522795A5
JP2003522795A5 JP2001559472A JP2001559472A JP2003522795A5 JP 2003522795 A5 JP2003522795 A5 JP 2003522795A5 JP 2001559472 A JP2001559472 A JP 2001559472A JP 2001559472 A JP2001559472 A JP 2001559472A JP 2003522795 A5 JP2003522795 A5 JP 2003522795A5
Authority
JP
Japan
Prior art keywords
norethisterone
derivative
testosterone undecanoate
administration
effective amount
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2001559472A
Other languages
English (en)
Japanese (ja)
Other versions
JP2003522795A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2001/000188 external-priority patent/WO2001060376A1/en
Publication of JP2003522795A publication Critical patent/JP2003522795A/ja
Publication of JP2003522795A5 publication Critical patent/JP2003522795A5/ja
Pending legal-status Critical Current

Links

JP2001559472A 2000-02-15 2001-02-15 ノルエチステロンからなる男性用避妊製剤 Pending JP2003522795A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US50372900A 2000-02-15 2000-02-15
US09/503,729 2000-02-15
EP00200493.5 2000-02-15
EP00200493 2000-02-15
PCT/IB2001/000188 WO2001060376A1 (en) 2000-02-15 2001-02-15 Male contraceptive formulation comprising norethisterone

Publications (2)

Publication Number Publication Date
JP2003522795A JP2003522795A (ja) 2003-07-29
JP2003522795A5 true JP2003522795A5 (https=) 2008-03-06

Family

ID=26071832

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001559472A Pending JP2003522795A (ja) 2000-02-15 2001-02-15 ノルエチステロンからなる男性用避妊製剤

Country Status (26)

Country Link
EP (2) EP1267885B8 (https=)
JP (1) JP2003522795A (https=)
KR (1) KR20020086905A (https=)
CN (1) CN1423560A (https=)
AT (2) ATE355844T1 (https=)
AU (1) AU2001230447A1 (https=)
BG (1) BG107066A (https=)
BR (1) BR0108411A (https=)
CA (1) CA2398063A1 (https=)
CY (1) CY1106639T1 (https=)
CZ (1) CZ20022691A3 (https=)
DE (2) DE60142647D1 (https=)
DK (1) DK1267885T3 (https=)
EE (1) EE200200454A (https=)
ES (1) ES2282230T3 (https=)
HK (1) HK1049442B (https=)
HU (1) HUP0300128A3 (https=)
IL (1) IL151219A0 (https=)
MX (1) MXPA02007675A (https=)
NO (1) NO20023607L (https=)
PL (1) PL357185A1 (https=)
PT (1) PT1267885E (https=)
RU (1) RU2002124602A (https=)
SI (1) SI1267885T1 (https=)
SK (1) SK11602002A3 (https=)
WO (1) WO2001060376A1 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10234525A1 (de) * 2002-07-25 2004-02-05 Schering Ag Zusammensetzung, enthaltend ein androgenes 11ß-Halogensteroid und ein Gestagen sowie männliches Kontrazeptivum auf Basis dieser Zusammensetzung
TW200404552A (en) * 2002-05-30 2004-04-01 Akzo Nobel Nv Self administered contraception
WO2004011663A2 (de) 2002-07-24 2004-02-05 Schering Aktiengesellschaft Mikrobiologische verfahren zur herstellung von 7alpha-substituierten 11alpha-hydroxysteroiden
AU2003251636B2 (en) * 2002-07-25 2009-10-22 Bayer Schering Pharma Aktiengesellschaft Composition containing an androgenous 11beta-halogen steroid and a progestational hormone, and male contraceptive based on said composition
JO2505B1 (en) * 2003-03-14 2009-10-05 باير شيرنغ فارما اكتنجيسيلشافت Pharmacy methods and formulations for obtaining acceptable serum testosterone levels
CN101352443B (zh) * 2007-07-23 2011-01-12 中国科学院动物研究所 哺乳动物雄性不育剂
PL3750538T3 (pl) 2018-03-23 2024-11-25 Pharmajor International Niehormonalne sposoby męskiej antykoncepcji obejmujące (r) -sylodosynę
KR20250142811A (ko) * 2024-03-22 2025-09-30 주식회사 에아스텍 노르에티스테론 에난테이트 화합물의 암의 예방 또는 치료 용도

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2714420A1 (de) * 1976-06-01 1977-12-08 Int Pregnancy Advisory Service Antikonzeptionsmittel zur verabreichung an mann und frau in einer gemeinsamen verabreichungspackung
US4210644A (en) 1978-02-23 1980-07-01 The Johns Hopkins University Male contraception
US5035891A (en) 1987-10-05 1991-07-30 Syntex (U.S.A.) Inc. Controlled release subcutaneous implant
CN1102095A (zh) * 1993-10-30 1995-05-03 浙江医科大学 长效雄激素类制剂——十一酸睾丸注射液
DE19650352A1 (de) * 1996-12-04 1998-07-30 Jenapharm Gmbh Oral wirksames Kombinationspräparat zur Kontrazeption für den Mann

Similar Documents

Publication Publication Date Title
ES2558030T3 (es) Método anticonceptivo oral multifásico de ciclo prolongado
WO2013016697A3 (en) 17-hydroxyprogesterone ester-containing oral compositions and related methods
TW200511997A (en) Methods and pharmaceutical compositions for reliable achievement of acceptable serum testosterone levels
AU2681300A (en) Solid oral dosage form containing an enhancer
AR073972A2 (es) Composiciones farmaceuticas para el tratamiento de carencias estrogenicas en la menopausia y para la prevencion de la osteoporosis en mujeres menopausicas
BR0010485A (pt) Formulações de derivados de eritromicina de liberação prolongada
BRPI0015567B8 (pt) composto, composição farmacêutica, forma de unidade de dosagem, uso da composição farmacêutica e método para preparar uma composição farmacêutica
WO2007145991A3 (en) Anti-inflammatory and analgesic compositions and related methods
CA2467237A1 (en) Method of preventing or treating benign gynaecological disorders
MY126960A (en) Administration of non-oral androgenic steroids to women
JP2009512658A5 (https=)
JP2007535519A5 (https=)
JP2008540482A5 (https=)
JP2003522795A5 (https=)
AU4862796A (en) Formulations of compounds as nanoparticulate dispersions in digestible oils or fatty acids
WO2006023496A3 (en) Vaginal cream compositions, kits thereof and methods of using thereof
WO2002042319A3 (en) 2-substituted estrogens as antiangiogenic agents
JP2002520286A5 (https=)
PT1227814E (pt) Composicao hormonal a base de acetato de nomegestrol e de um estrogenio e sua utilizacao
WO2000054780A3 (en) Corticosteroid formulation
JP2008522972A5 (https=)
RU2002124602A (ru) Композиция для мужской контрацепции, включающая норэтистерон
JP2002527481A5 (https=)
JP2002541153A5 (https=)
JP2002539135A5 (https=)